Found 4 matching trials
Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer
PHASE2The purpose of this study is to study the effects of EPI-7386 in combinatio...
Location
University Hospitals Cleveland Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center
EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC
PHASE1This is a Phase 1/2 study of EPI-7386 orally administered in combination wi...
Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer
PHASE1This is a phase I, clinical research study of EPI-7386, an investigational ...
Location
Hematology Oncology Associates of the Treasure Coast
A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)
PHASE1The purpose of this study is to determine safety, including dose limiting t...
Location
Chesapeake Urology Research Associates